Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we wish to inform you that ESG Risk Assessments & Insights Limited, a SEBI-registered ESG rating provider, has voluntarily assigned an ESG rating of 68 (Strong) for the Financial Year 2024-25 as part of its annual ESG assessment process.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Limited has received an ESG rating of 68, which is classified as 'Strong', from ESG Risk Assessments & Insights Limited, a SEBI-registered ESG rating provider. This rating was assigned voluntarily as part of the provider's annual ESG assessment process for Financial Year 2024-25. The disclosure was made under SEBI's Listing Obligations and Disclosure Requirements Regulation 30. A 'Strong' ESG rating suggests the company performs well on environmental, social, and governance parameters compared to industry peers.
A strong ESG rating can enhance Wockhardt's appeal to ESG-focused institutional investors and may support its sustainability credentials, but it is unlikely to have an immediate direct impact on stock price or financial performance.